About 1.5 million people died of tuberculosis (TB) in 2017, making it the most lethal infectious disease worldwide. A growing rise in drug-resistant TB is a major obstacle to successfully treating the illness. Now, researchers have found a compound that prevents and even reverses resistance to isoniazid, the most widely used antibiotic for treating tuberculosis.